Please click here to download the printable version of the program.

Tuesday, 17 March 2020

08:00 Arrival / Networking
09:00
Session 1: Welcome
This session will give an overview of WADA’s 2020 Annual Symposium, including presenting its objectives.
09:15 Session 2: Opening remarks by WADA President and Director General
This session will include a keynote speech by the new WADA President, Witold Bańka, and an update on WADA’s strategic priorities by WADA Director General, Olivier Niggli.
10:00 Networking break
10:45 Session 3: An overview of the most impactful changes to the Code and Standards
This session will provide a summary of the main changes to the 2021 World Anti-Doping Code (Code), with a focus on the impact such changes will have on the anti-doping community. The presentation will be followed by a roundtable with National Anti-Doping Organizations (NADOs), International Federations (IFs), Major Event Organizers (MEOs), Athlete representatives and WADA.
11:15 Session 4: What is expected of ADOs in preparation for the 2021 Code and Standards?
With the 2021 Code and International Standards (Standards) set to come into effect on 1 January 2021, all Anti-Doping Organizations (ADOs) will be required to adjust their legal framework; as well as, their programs to meet the new requirements.
This session will hear from a cross-section of bodies – including NADOs; Regional Anti-Doping Organizations (RADOs); IFs; the International Testing Agency (ITA); and, the Institute of National Anti-Doping Organizations (iNADO) on how they are preparing for the implementation of the 2021 Code and Standards. It is intended that this session will engage in an active discussion using questions/challenges identified by the audience.
12:30 Networking lunch
12:45 Working Lunch: The Prohibited List
This session will present some of the challenges, trends and future perspectives that will guide the Prohibited List experts and broader anti-doping community in the evolution of this International Standard for the years to come.
This session will be in English only – no French interpretation will be offered.
13:45 Session 5a: Code compliance in practice (ISCCS)
This session will review the changes made as part of the 2021 International Standard for Code Compliance by Signatories (ISCCS) and look at the future of WADA’s Compliance Monitoring Program; as well as, how these may impact Code Signatories.
Session 5b: TUE management in practice (ISTUE)
This session will be divided into three sections. First, we will provide a global overview of Therapeutic Use Exemptions (TUEs) entered in ADAMS. We will then address practical issues, including the key criteria for granting prospective and retroactive TUEs as per the 2021 ISTUE. Finally, we will present a number of cases, demonstrating some of the challenges faced by ADOs and TUE Committee Physicians.
Session 5c: The new Education Standard (ISE) and Guidelines in practice
This session will focus on the implementation of the new ISE by stakeholders and will present an outline of new Guidelines for Education. The participants will receive practical information on key aspects of the ISE and how to implement them with the use of the new Guidelines.
14:45 Networking break
15:15 Session 6a: The new Results Management Standard (ISRM) in practice
A panel of experts will discuss independence vs impartiality; as well as, hearing panel composition and competences; fair hearings; timely decisions; and, other major topics that were addressed as part of the ISRM drafting process. The session will also discuss delegation of results management in the case of Major Events; and, the new Article 10.8, which replaces articles on Prompt Admission and Timely Admission. Stakeholders will be provided with the necessary information to understand this change and how to apply this new article in the future.
Session 6b: Anti-doping privacy obligations in practice (ISPPPI)
This session will provide practical guidance to individuals responsible for privacy within their organization, focusing on how to operationalize the ISPPPI at the same time as other legislative and regulatory requirements. A panel of privacy professionals from the anti-doping community will provide insight into their approach to anti-doping privacy obligations, and will actively engage with questions from participants. Participants will also engage in a benchmarking exercise through interactive survey questions.
Session 6c: Testing and investigations in practice (ISTI)
This session will provide a practical overview of the main changes of the revised ISTI and what is required to effectively implement a compliant testing program.
The session will cover such areas as risk assessment, development of a Test Distribution Plan; Whereabouts Pools; ADO collaboration; strategic testing (including the Athlete Biological Passport); the Technical Document for Sport Specific Analysis; sample storage and re-analysis; and, intelligence gathering. The session will also include a snap shot of how ADOs can use Next Gen ADAMS to assist with their implementation of the ISTI.
The session will conclude with a panel style question and answer (Q&A) session.
16:30 Session 7: A Q&A Session with WADA President, Vice President and Director General
This session will provide participants with the opportunity to interact directly with key members of WADA’s leadership for a Q&A session. The new WADA President, Witold Bańka; new VicePresident, Yang Yang; and, Director General, Olivier Niggli, will respond to questions from the audience.
17:30 Welcome Cocktail
19:00 End of Day 1

 

Wednesday, 18 March 2020

 

08:30 Session 8a: Code compliance in practice (ISCCS)
This session will review the changes made as part of the 2021 International Standard for Code Compliance by Signatories (ISCCS) and look at the future of WADA’s Compliance Monitoring Program; as well as, how these may impact Code Signatories.
Session 8b: TUE management in practice (ISTUE)
This session will be divided into three sections. First, we will provide a global overview of Therapeutic Use Exemptions (TUEs) entered in ADAMS. We will then address practical issues, including the key criteria for granting prospective and retroactive TUEs as per the 2021 ISTUE. Finally, we will present a number of cases, demonstrating some of the challenges faced by ADOs and TUE Committee Physicians.
Session 8c: The new Education Standard (ISE) and Guidelines in practice
This session will focus on the implementation of the new ISE by stakeholders and will present an outline of new Guidelines for Education. The participants will receive practical information on key aspects of the ISE and how to implement them with the use of the new Guidelines.
09:45 Session 9a: The new Results Management Standard (ISRM) in practice
A panel of experts will discuss independence vs impartiality; as well as, hearing panel composition and competences; fair hearings; timely decisions; and, other major topics that were addressed as part of the ISRM drafting process. The session will also discuss delegation of results management in the case of Major Events; and, the new Article 10.8, which replaces articles on Prompt Admission and Timely Admission. Stakeholders will be provided with the necessary information to understand this change and how to apply this new article in the future.
Session 9b: Anti-doping privacy obligations in practice (ISPPPI)
This session will provide practical guidance to individuals responsible for privacy within their organization, focusing on how to operationalize the ISPPPI at the same time as other legislative and regulatory requirements. A panel of privacy professionals from the anti-doping community will provide insight into their approach to anti-doping privacy obligations, and will actively engage with questions from participants. Participants will also engage in a benchmarking exercise through interactive survey questions.
Session 9c: Testing and investigations in practice (ISTI)
This session will provide a practical overview of the main changes of the revised ISTI and what is required to effectively implement a compliant testing program.
The session will cover such areas as risk assessment, development of a Test Distribution Plan; Whereabouts Pools; ADO collaboration; strategic testing (including the Athlete Biological Passport); the Technical Document for Sport Specific Analysis; sample storage and re-analysis; and, intelligence gathering. The session will also include a snap shot of how ADOs can use Next Gen ADAMS to assist with their implementation of the ISTI.
The session will conclude with a panel style question and answer (Q&A) session.
10:45 Networking break
11:15 Session 10: The Athletes’ Anti-Doping Rights Act – How can ADOs support its Implementation and Promise
Taking effect in conjunction with the 2021 World Anti-Doping Program, the Act seeks to ensure athletes’ rights within anti-doping are clearly set out, accessible, and universally applicable.  This session will provide an overview of the elements of the Act which are found in the Code and various International Standards, so that ADOs can ensure they are providing athletes the necessary protections in practice.  The session will also explore athlete-centered best practices which ADOs may wish to consider, in order to deliver on the aspirational aspects of the Act.
12:15 Networking lunch
12:45 Working Lunch: International Standard for Laboratories (ISL)
This session will offer an overview of the different elements of the current ISL version 10 that entered into effect on 1 November 2019; as well as, the future version 11.0. Version 11.0 will be presented for approval by WADA’s Executive Committee in May or September 2020 with a view to it taking effect on 1 January 2021 along with the 2021 Code and other Standards. Participants may recall that the ISL followed a different review timeline due to certain changes that required earlier release than 2021.
This session will be in English only – no French interpretation will be offered.
13:45 Session 11a: An update on the development of tools to measure doping prevalence
The ability to define the prevalence of doping in sport and countries is essential to understanding doping and to objectively measuring the impact of the global anti-doping program. In 2017, WADA re-established a Prevalence Working Group with the aim of developing a tool, or a set of tools, to be used by stakeholders to assess prevalence in their sport or country. To test their strategy, three major studies were conducted in 2019; and, we expect that the approach should be close to finalization in the second half of 2020. This session will give an overview of the outcomes of this work and prepare stakeholders to use this approach in 2021.
Session 11b: What should be the next steps for Governments in the fight against doping in sport?
Governments are key to the fight against doping in sport. From the beginning, they have been instrumental in the creation of WADA. Governments can take actions through legislation, policies, regulatory and administrative practices that cannot be undertaken by the sport movement or by WADA.
However, actions taken by Governments vary from country to country and can be very diverse. This session will give an overview of the priorities that WADA believes governments should focus their actions on; as well as, best mechanisms to ensure a coordinated approach to deliver on these priorities.
Session 11c: An update on the new and upcoming features of ADAMS
This session will introduce participants to the basics of the Anti-Doping Administration & Management System (ADAMS), familiarize them with the support and training resources available, and provide a full update on the status of the Next Gen project.
15:00 Session 12a: An overview of what the social science research is telling us
This session will present the latest social science research findings from projects funded by WADA or supported by WADA in other ways. By the end of the session, participants will have a better understanding of WADA’s social science research priorities and what the latest research means for stakeholders as practitioners. We will also look at the athlete perspective and how athletes can be more effectively engaged in this area.
Session 12b: How can Governments contribute to building anti-doping capacity worldwide?
Governments are key contributors to building capacity of the anti-doping in sport system. Government commitments towards and funding of anti-doping activities however, differs greatly from one country to another. The capacity to fight doping in sport varies significantly between regions and countries.
A number of stakeholders have already contributed directly to building capacity worldwide. While these measures have contributed to minimizing the disparities worldwide, they have not solved this issue. In certain areas of the world, more could and should be done to have a stronger worldwide system. This session will explore the steps that can be taken by Governments to strengthen the system worldwide; the mechanisms Governments can use to strengthen their support to areas of the world most in need; and the value of soft diplomacy programs.
Session 12c: An outlook on future analytical detection methods
Analytical science applied to the anti-doping field has made great progress over the past ten years, as demonstrated by the effectiveness of the re-analysis programs conducted by some ADOs.
A number of new approaches, ranging from the collection of samples to the analysis of data, are currently in the research pipeline and may soon revolutionize the way samples are collected and data are analyzed by the anti-doping community.
This session will explore the most advanced concepts and methods (e.g. Dry Blood Spot, Artificial Intelligence) currently under research. The anticipated impact such methods will have on antidoping analysis in the future will also be addressed.
16:00 Networking break
16:30 Session 13: Symposium wrap-up
This session will include the key outcomes and takeaways from each Symposium session, presented by the respective session leads.
17:15 End of the Symposium